It’s almost time for the annual Advanced Technologies and Treatments for Diabetes conference!

Location:

Austria Centre
Bruno-Kreisky-Platz 1, 1220 Wien, Austria

Exhibit Hall Hours:

  • 2/14 – 6pm – 7:30pm
  • 2/15 – 9:30am – 3:30pm
  • 2/16 – 9:30am – 3:30pm
  • 2/17 – 9:30am – 1:45pm

This year our booth #41  will feature 3 fantastic presentations in our very own Product Theatre, Thursday, 2/15 & Friday, 2/16. See the schedule below:

Thursday, 2/15:

10am – Eversense Clinical Experience: A Year in Review by Dorothee Deiss, MD, Medicover Berlin-Mitte

12 noon – A Long-Term Approach to Glucose Monitoring: Introducing the First 6 Month Sensor by Alexander Abitbol, MDCM, FRCPC, LMC Healthcare

2:30pm – Usability of a Long-Term Continuous Glucose Monitoring System by Andrew DeHennis, PhD, Senseonics Inc

Friday, 2/16:

10am – A Long-Term Approach to Glucose Monitoring: Introducing the First 6 Month Sensor by Alexander Abitbol, MDCM, FRCPC, LMC Healthcare

12 noon – Eversense Clinical Experience: A Year in Review by Dorothee Deiss, MD, Medicover Berlin-Mitte

2:30pm – Usability of a Long-Term Continuous Glucose Monitoring System by Andrew DeHennis, PhD, Senseonics Inc

Don’t miss out on these great presentations. You will also have the chance to interact with each speakers, so bring your questions and engage in the conversation. While visiting our booth, be sure to check out the new smart tablet bar to demo the great features of our app for yourself and see a professional insertion and removal demonstration of the Eversense Sensor.

Also, be sure to attend and view the various Oral presentations, E-posters and E-poster discussions.

Oral Presentation, Dr Alexander Abitbol, 2/17 @8:30 – 10am, Hall M

ATTD8-0155 (10 mins long)

  • Longevity of an Implantable CGM System During a 180 Day Study

E-Poster Discussion, Dr Andrew DeHennis  2/16 @10:05am – 10:25am, Station 6

ATTD8-0152 (5 mins long)

  • Usability, Safety, and Benefits of Multiple Sensor Use of a Long-Term Implantable Continuous Glucose Monitoring System

Posters

ATTD8-0285

  • Long Term Implantable Continuous Glucose Monitoring(CGM) System Demonstrates Benefits in Glycemic Control with Wear Compliance

ATTD8-0429

  • Evolution of Glucose Monitoring: Choosing the Right System to Optimize Patient Experience

For more information on the ATTD Program or to Register, click here.

By |2018-02-09T20:16:24+00:00February 1st, 2018|ATTD 2018|0 Comments

About the Author:

Leave A Comment